Fertility Preservation With Ovarian Tissue Freezing (PTO)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03674164|
Recruitment Status : Not yet recruiting
First Posted : September 17, 2018
Last Update Posted : September 17, 2018
The purpose of this study is to obtain ovarian tissue from female patients undergoing gonadotoxic treatments or gonadal ablating surgery, and that in consequence may see their future fertility impaired. Participants will be offered to preserve (freeze) and use ovarian tissue for the purpose of conceiving in the future.
Although, 86 live births have been reported with ovarian tissue cryo-preservation and grafting, the procedure is still considered experimental.
This research, will help us to learn and validate how to perform ovarian tissue cryo-preservation and thawing in the fertility preservation context.
|Condition or disease||Intervention/treatment||Phase|
|Cancer Hematologic Disorder Infertility Ovarian Failure||Other: Ovarian Cryopreservation||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||250 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Fertility Preservation With Ovarian Tissue Freezing|
|Estimated Study Start Date :||September 10, 2019|
|Estimated Primary Completion Date :||December 31, 2023|
|Estimated Study Completion Date :||December 31, 2023|
- Other: Ovarian Cryopreservation
Surgical ovarian removal and vitrification
- Cryopreservation of ovarian tissu by vitrification [ Time Frame: 5 years ]Measure the fertility rate of cryopreservation and grafting by ovarian tissue vitrification.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03674164
|Contact: Julio Saumet Chilito, MD||5143454931 ext firstname.lastname@example.org|
|Principal Investigator:||Julio Saumet Chilito, MD||Physician|